NEBIVOLOL HYDROCHLORIDE

NEBIVOLOL HYDROCHLORIDE was reported 34143 times

These side effects are most commonly reported by patients taking NEBIVOLOL HYDROCHLORIDE:

# Side effect Count
0 FATIGUE 1883
1 DIARRHOEA 1833
2 DYSPNOEA 1745
3 DRUG INEFFECTIVE 1660
4 NAUSEA 1632
5 HEADACHE 1451
6 DIZZINESS 1433
7 ACUTE KIDNEY INJURY 1345
8 OFF LABEL USE 1289
9 ASTHENIA 1115
10 FALL 1071
11 HYPOTENSION 1005
12 HYPERTENSION 950
13 MALAISE 919
14 VOMITING 902
15 ANAEMIA 896
16 PAIN 895
17 BLOOD PRESSURE INCREASED 853
18 DRUG INTERACTION 810
19 ARTHRALGIA 805
20 COUGH 775
21 PRURITUS 759
22 WEIGHT DECREASED 739
23 RASH 719
24 PNEUMONIA 704
25 PAIN IN EXTREMITY 673
26 INSOMNIA 659
27 RENAL FAILURE 646
28 PYREXIA 636
29 DECREASED APPETITE 607
30 DEATH 582
31 CHEST PAIN 580
32 ANXIETY 556
33 CONDITION AGGRAVATED 544
34 MYALGIA 532
35 ABDOMINAL PAIN 530
36 CONSTIPATION 520
37 BRADYCARDIA 516
38 OEDEMA PERIPHERAL 515
39 BACK PAIN 513
40 ABDOMINAL PAIN UPPER 503
41 CHRONIC KIDNEY DISEASE 501
42 GAIT DISTURBANCE 488
43 WEIGHT INCREASED 486
44 SYNCOPE 476
45 FEELING ABNORMAL 475
46 MUSCLE SPASMS 462
47 SOMNOLENCE 445
48 ATRIAL FIBRILLATION 443
49 GENERAL PHYSICAL HEALTH DETERIORATION 438
50 CONFUSIONAL STATE 426
51 HYPONATRAEMIA 409
52 PALPITATIONS 409
53 URINARY TRACT INFECTION 397
54 ALOPECIA 392
55 THROMBOCYTOPENIA 391
56 DEPRESSION 389
57 PERIPHERAL SWELLING 386
58 HYPERKALAEMIA 385
59 TREMOR 384
60 PARAESTHESIA 381
61 ERYTHEMA 373
62 CARDIAC FAILURE 368
63 ABDOMINAL DISCOMFORT 355
64 DEHYDRATION 346
65 RENAL IMPAIRMENT 346
66 FLUSHING 342
67 MUSCULAR WEAKNESS 338
68 COVID-19 331
69 CEREBROVASCULAR ACCIDENT 329
70 HYPOKALAEMIA 328
71 LOSS OF CONSCIOUSNESS 321
72 DYSPEPSIA 316
73 EPISTAXIS 316
74 HYPERHIDROSIS 307
75 NEUTROPENIA 305
76 MYOCARDIAL INFARCTION 302
77 PRODUCT DOSE OMISSION ISSUE 302
78 CHEST DISCOMFORT 299
79 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 298
80 BLOOD GLUCOSE INCREASED 295
81 GASTROINTESTINAL HAEMORRHAGE 292
82 HYPOAESTHESIA 289
83 PRODUCT USE IN UNAPPROVED INDICATION 286
84 HEART RATE INCREASED 285
85 DRUG DOSE OMISSION 281
86 VISION BLURRED 275
87 HYPERSENSITIVITY 271
88 DRUG HYPERSENSITIVITY 266
89 HAEMOGLOBIN DECREASED 265
90 MEMORY IMPAIRMENT 261
91 BLOOD CREATININE INCREASED 260
92 NASOPHARYNGITIS 260
93 ABDOMINAL DISTENSION 259
94 JOINT SWELLING 250
95 INJECTION SITE PAIN 248
96 PULMONARY EMBOLISM 248
97 SEPSIS 248
98 LACTIC ACIDOSIS 247
99 URTICARIA 246
100 TOXICITY TO VARIOUS AGENTS 242
101 DRY MOUTH 241
102 BALANCE DISORDER 240
103 PRODUCT USE ISSUE 240
104 VERTIGO 236
105 CONTUSION 234
106 BLOOD PRESSURE DECREASED 230
107 SINUSITIS 230
108 GASTROOESOPHAGEAL REFLUX DISEASE 225
109 HEART RATE DECREASED 225
110 VISUAL IMPAIRMENT 224
111 CHILLS 222
112 DYSPHAGIA 220
113 ANGINA PECTORIS 216
114 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216
115 INCORRECT DOSE ADMINISTERED 216
116 HYPOGLYCAEMIA 215
117 BRONCHITIS 213
118 TACHYCARDIA 210
119 NEUROPATHY PERIPHERAL 209
120 BURNING SENSATION 206
121 DRUG INTOLERANCE 205
122 HOT FLUSH 202
123 RHABDOMYOLYSIS 200
124 PSORIASIS 197
125 INFECTION 195
126 RESPIRATORY FAILURE 192
127 CARDIAC ARREST 188
128 INFLUENZA 186
129 SEIZURE 186
130 CARDIAC FAILURE CONGESTIVE 185
131 ASTHMA 183
132 HYPOMAGNESAEMIA 182
133 INTERSTITIAL LUNG DISEASE 182
134 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 180
135 DYSPNOEA EXERTIONAL 177
136 FLATULENCE 177
137 OVERDOSE 177
138 PLATELET COUNT DECREASED 175
139 HEPATIC ENZYME INCREASED 172
140 MIGRAINE 172
141 ARTHRITIS 171
142 RECTAL HAEMORRHAGE 171
143 FEELING HOT 170
144 INTENTIONAL PRODUCT MISUSE 169
145 ARRHYTHMIA 168
146 PLEURAL EFFUSION 166
147 PRODUCT QUALITY ISSUE 166
148 DEEP VEIN THROMBOSIS 165
149 METABOLIC ACIDOSIS 165
150 CARDIAC DISORDER 164
151 COMPLETED SUICIDE 163
152 HALLUCINATION 163
153 DYSGEUSIA 162
154 SLEEP DISORDER 160
155 ANGIOEDEMA 159
156 HAEMORRHAGE 158
157 SWELLING 157
158 END STAGE RENAL DISEASE 156
159 DISEASE PROGRESSION 155
160 HYPOCALCAEMIA 155
161 DRY SKIN 154
162 GASTROINTESTINAL DISORDER 154
163 INTENTIONAL PRODUCT USE ISSUE 153
164 LETHARGY 153
165 OROPHARYNGEAL PAIN 153
166 OEDEMA 149
167 LEUKOPENIA 147
168 NECK PAIN 147
169 WHEEZING 147
170 BLOOD CHOLESTEROL INCREASED 146
171 MUSCULOSKELETAL STIFFNESS 145
172 PULMONARY OEDEMA 144
173 AGITATION 143
174 NERVOUSNESS 143
175 WHITE BLOOD CELL COUNT DECREASED 143
176 HOSPITALISATION 142
177 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 141
178 CHOLESTASIS 138
179 FEBRILE NEUTROPENIA 138
180 HYPERTENSIVE CRISIS 138
181 PRODUCT SUBSTITUTION ISSUE 138
182 RENAL FAILURE ACUTE 138
183 ORTHOSTATIC HYPOTENSION 137
184 TRANSIENT ISCHAEMIC ATTACK 137
185 MUSCULOSKELETAL PAIN 136
186 COMA 135
187 MELAENA 135
188 PANCYTOPENIA 135
189 PRESYNCOPE 135
190 UNEVALUABLE EVENT 135
191 INFLUENZA LIKE ILLNESS 134
192 RASH ERYTHEMATOUS 134
193 ACUTE MYOCARDIAL INFARCTION 132
194 HAEMATOCHEZIA 132
195 AMNESIA 131
196 DIABETES MELLITUS 131
197 LUNG DISORDER 131
198 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 128
199 ISCHAEMIC STROKE 128
200 RASH PRURITIC 128
201 CATARACT 127
202 HAEMATOMA 127
203 TUBULOINTERSTITIAL NEPHRITIS 127
204 MALIGNANT NEOPLASM PROGRESSION 126
205 DYSPHONIA 125
206 ELECTROCARDIOGRAM QT PROLONGED 125
207 INTENTIONAL OVERDOSE 125
208 STOMATITIS 125
209 THROMBOSIS 125
210 CEREBRAL HAEMORRHAGE 124
211 SUICIDE ATTEMPT 124
212 SWELLING FACE 123
213 DISTURBANCE IN ATTENTION 122
214 CORONARY ARTERY DISEASE 121
215 ILLNESS 121
216 TINNITUS 120
217 FLUID RETENTION 119
218 INTERNATIONAL NORMALISED RATIO INCREASED 119
219 PANCREATITIS 119
220 SKIN EXFOLIATION 119
221 URINARY RETENTION 119
222 BLOOD PRESSURE FLUCTUATION 118
223 EOSINOPHILIA 115
224 INFLAMMATION 115
225 SEPTIC SHOCK 114
226 UPPER RESPIRATORY TRACT INFECTION 113
227 ERECTILE DYSFUNCTION 112
228 OSTEOARTHRITIS 112
229 SUICIDAL IDEATION 112
230 DRY EYE 111
231 DYSARTHRIA 111
232 HAEMATURIA 111
233 SURGERY 110
234 DISCOMFORT 109
235 DRUG ABUSE 109
236 RHEUMATOID ARTHRITIS 109
237 THERAPEUTIC RESPONSE UNEXPECTED 109
238 ADVERSE DRUG REACTION 108
239 DISORIENTATION 108
240 OXYGEN SATURATION DECREASED 108
241 PANCREATITIS ACUTE 108
242 RENAL DISORDER 108
243 RHINORRHOEA 108
244 THERAPY CESSATION 107
245 DYSURIA 106
246 EYE PAIN 106
247 PRODUCT DOSE OMISSION 106
248 ALANINE AMINOTRANSFERASE INCREASED 104
249 BLOOD PRESSURE ABNORMAL 104
250 BONE PAIN 104
251 HERPES ZOSTER 104
252 SWOLLEN TONGUE 104
253 BLOOD POTASSIUM DECREASED 102
254 INJECTION SITE ERYTHEMA 101
255 PRODUCTIVE COUGH 101
256 RASH MACULO-PAPULAR 101
257 RENAL INJURY 101
258 SPEECH DISORDER 101
259 BLISTER 100
260 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 100
261 DEPRESSED MOOD 99
262 GOUT 98
263 LOWER RESPIRATORY TRACT INFECTION 98
264 ASPARTATE AMINOTRANSFERASE INCREASED 97
265 FEELING COLD 97
266 NEPHROLITHIASIS 97
267 MOBILITY DECREASED 95
268 NIGHTMARE 95
269 COGNITIVE DISORDER 94
270 CYSTITIS 94
271 HYPERGLYCAEMIA 94
272 POLLAKIURIA 94
273 NEPHROGENIC ANAEMIA 93
274 BLOOD CREATINE PHOSPHOKINASE INCREASED 92
275 EYE IRRITATION 92
276 HAEMOPTYSIS 92
277 NASAL CONGESTION 92
278 NIGHT SWEATS 92
279 HYPOTHYROIDISM 91
280 STAPHYLOCOCCAL INFECTION 91
281 DRUG-INDUCED LIVER INJURY 90
282 RASH MACULAR 90
283 SKIN DISCOLOURATION 90
284 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 90
285 STRESS 89
286 HEAD INJURY 88
287 MEDICATION ERROR 86
288 OCULAR HYPERAEMIA 86
289 SLEEP APNOEA SYNDROME 86
290 COLITIS 85
291 DIVERTICULITIS 85
292 TYPE 2 DIABETES MELLITUS 85
293 ANAPHYLACTIC REACTION 84
294 HEPATOCELLULAR INJURY 84
295 CELLULITIS 83
296 MUCOSAL INFLAMMATION 83
297 THROAT IRRITATION 83
298 FUNGAL INFECTION 82
299 NO ADVERSE EVENT 82
300 THERAPY INTERRUPTED 82
301 APHASIA 81
302 ARTHROPATHY 81
303 GASTRITIS 81
304 GLYCOSYLATED HAEMOGLOBIN INCREASED 81
305 JAUNDICE 81
306 HAEMORRHOIDS 80
307 HYPOACUSIS 80
308 INJECTION SITE BRUISING 80
309 PRODUCT PRESCRIBING ERROR 80
310 CARDIOGENIC SHOCK 79
311 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79
312 C-REACTIVE PROTEIN INCREASED 78
313 GLOMERULAR FILTRATION RATE DECREASED 78
314 OSTEOPOROSIS 78
315 VENTRICULAR EXTRASYSTOLES 78
316 ADVERSE EVENT 77
317 BLOOD SODIUM DECREASED 77
318 DIPLOPIA 77
319 EMOTIONAL DISTRESS 77
320 ECZEMA 76
321 ELECTROLYTE IMBALANCE 76
322 AGRANULOCYTOSIS 75
323 RED BLOOD CELL COUNT DECREASED 75
324 RESPIRATORY TRACT INFECTION 75
325 SOPOR 75
326 UPPER GASTROINTESTINAL HAEMORRHAGE 75
327 BLOOD GLUCOSE DECREASED 74
328 BLOOD TRIGLYCERIDES INCREASED 74
329 CARDIO-RESPIRATORY ARREST 74
330 INTERVERTEBRAL DISC PROTRUSION 74
331 NOCTURIA 74
332 PULMONARY HYPERTENSION 74
333 LIP SWELLING 73
334 LYMPHADENOPATHY 73
335 VISUAL ACUITY REDUCED 73
336 CHOLELITHIASIS 72
337 HAEMATOCRIT DECREASED 72
338 HEPATIC CYTOLYSIS 72
339 MUSCULOSKELETAL DISCOMFORT 72
340 PALLOR 72
341 PSORIATIC ARTHROPATHY 72
342 SKIN BURNING SENSATION 72
343 WOUND 72
344 ACUTE RESPIRATORY FAILURE 71
345 EYE SWELLING 71
346 GASTRIC ULCER 71
347 INJECTION SITE HAEMORRHAGE 71
348 IRRITABILITY 71
349 PERIPHERAL COLDNESS 71
350 EYE DISORDER 70
351 MENTAL DISORDER 70
352 GASTRIC DISORDER 69
353 PANIC ATTACK 69
354 SINUS BRADYCARDIA 69
355 ATRIOVENTRICULAR BLOCK 68
356 BLOOD POTASSIUM INCREASED 68
357 DRUG EFFECT DECREASED 68
358 ELECTROCARDIOGRAM ABNORMAL 68
359 HALLUCINATION, VISUAL 68
360 HEART RATE IRREGULAR 68
361 HEPATIC STEATOSIS 68
362 RESTLESS LEGS SYNDROME 68
363 THERAPY NON-RESPONDER 68
364 ANAPHYLACTIC SHOCK 67
365 DISEASE RECURRENCE 67
366 DYSKINESIA 67
367 DYSSTASIA 67
368 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 67
369 THERAPEUTIC RESPONSE DECREASED 67
370 UNDERDOSE 67
371 ASCITES 66
372 DRUG LEVEL INCREASED 66
373 OESOPHAGITIS 66
374 SPINAL OSTEOARTHRITIS 66
375 WHITE BLOOD CELL COUNT INCREASED 66
376 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66
377 DEVICE ISSUE 65
378 LIMB DISCOMFORT 65
379 NEURALGIA 65
380 AGEUSIA 64
381 EXTRASYSTOLES 64
382 TREATMENT NONCOMPLIANCE 64
383 URINARY INCONTINENCE 64
384 ALTERED STATE OF CONSCIOUSNESS 63
385 ROAD TRAFFIC ACCIDENT 63
386 ABNORMAL DREAMS 62
387 CIRCULATORY COLLAPSE 62
388 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62
389 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62
390 SHOCK HAEMORRHAGIC 62
391 CONVULSION 61
392 HYPERSOMNIA 61
393 MITRAL VALVE INCOMPETENCE 61
394 RESTLESSNESS 61
395 CONTRAINDICATED PRODUCT ADMINISTERED 60
396 CORONARY ARTERY OCCLUSION 60
397 HYPOXIA 60
398 INJECTION SITE PRURITUS 60
399 LEUKOCYTOSIS 60
400 PNEUMONITIS 60
401 PULMONARY MASS 60
402 SKIN ULCER 60
403 HIP FRACTURE 59
404 MULTIPLE SCLEROSIS RELAPSE 59
405 NEUTROPHIL COUNT DECREASED 59
406 SPRUE-LIKE ENTEROPATHY 59
407 VENTRICULAR TACHYCARDIA 59
408 ACUTE RESPIRATORY DISTRESS SYNDROME 58
409 BASAL CELL CARCINOMA 58
410 BRONCHOSPASM 57
411 EJECTION FRACTION DECREASED 57
412 HAEMORRHAGIC STROKE 57
413 LIVER DISORDER 57
414 PERICARDIAL EFFUSION 57
415 PULMONARY FIBROSIS 57
416 BLOOD PRESSURE INADEQUATELY CONTROLLED 56
417 CHROMATURIA 56
418 FEMUR FRACTURE 56
419 HIATUS HERNIA 56
420 KIDNEY INFECTION 56
421 ORAL PAIN 56
422 RESPIRATORY DISTRESS 56
423 RETCHING 56
424 SUBDURAL HAEMATOMA 56
425 BREAST CANCER 55
426 COVID-19 PNEUMONIA 55
427 ENCEPHALOPATHY 55
428 EXPIRED PRODUCT ADMINISTERED 55
429 INFUSION RELATED REACTION 55
430 IRRITABLE BOWEL SYNDROME 55
431 LACRIMATION INCREASED 55
432 OSTEONECROSIS OF JAW 55
433 SKIN LESION 55
434 BLOOD PRESSURE SYSTOLIC INCREASED 54
435 ILL-DEFINED DISORDER 54
436 IMPAIRED HEALING 54
437 NERVOUS SYSTEM DISORDER 54
438 PROTEINURIA 54
439 ANURIA 53
440 ATRIOVENTRICULAR BLOCK COMPLETE 53
441 DRUG EFFECT INCOMPLETE 53
442 FAECES DISCOLOURED 53
443 HAEMATEMESIS 53
444 HAEMORRHAGIC ANAEMIA 53
445 HEAD DISCOMFORT 53
446 HYPERTHYROIDISM 53
447 INJURY 53
448 INTESTINAL OBSTRUCTION 53
449 RASH GENERALISED 53
450 ABDOMINAL PAIN LOWER 52
451 BLOOD UREA INCREASED 52
452 COLD SWEAT 52
453 DEVICE MALFUNCTION 52
454 FULL BLOOD COUNT DECREASED 52
455 INJECTION SITE SWELLING 52
456 MOVEMENT DISORDER 52
457 TRICUSPID VALVE INCOMPETENCE 52
458 CORONARY ARTERY STENOSIS 51
459 DEMENTIA 51
460 DRUG PRESCRIBING ERROR 51
461 HEMIPARESIS 51
462 INJECTION SITE REACTION 51
463 IRON DEFICIENCY ANAEMIA 51
464 LIMB INJURY 51
465 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51
466 THROAT TIGHTNESS 51
467 VASCULITIS 51
468 BLOOD BILIRUBIN INCREASED 50
469 BRAIN FOG 50
470 DELIRIUM 50
471 EPILEPSY 50
472 GLAUCOMA 50
473 HYPOPHAGIA 50
474 BURSITIS 49
475 ERUCTATION 49
476 GAIT INABILITY 49
477 JOINT STIFFNESS 49
478 PRURITUS GENERALISED 49
479 RECALLED PRODUCT ADMINISTERED 49
480 RESPIRATORY DISORDER 49
481 TACHYPNOEA 49
482 CEREBRAL HAEMATOMA 48
483 CRYING 48
484 DEPRESSED LEVEL OF CONSCIOUSNESS 48
485 EXERCISE TOLERANCE DECREASED 48
486 EYE PRURITUS 48
487 GALLBLADDER DISORDER 48
488 SEASONAL ALLERGY 48
489 TENDON RUPTURE 48
490 ACUTE CORONARY SYNDROME 47
491 CROHN^S DISEASE 47
492 DIABETES MELLITUS INADEQUATE CONTROL 47
493 DRUG ADMINISTRATION ERROR 47
494 EAR INFECTION 47
495 EYELID OEDEMA 47
496 HERNIA 47
497 INTENTIONAL DOSE OMISSION 47
498 LIVER FUNCTION TEST ABNORMAL 47
499 MUSCLE TIGHTNESS 47
500 MYOCARDIAL ISCHAEMIA 47
501 PLASMA CELL MYELOMA 47
502 POOR QUALITY SLEEP 47
503 SQUAMOUS CELL CARCINOMA 47
504 TENDONITIS 47
505 LOCALISED INFECTION 46
506 MIDDLE INSOMNIA 46
507 PAIN IN JAW 46
508 POISONING DELIBERATE 46
509 COAGULOPATHY 45
510 FEAR 45
511 GASTROINTESTINAL MOTILITY DISORDER 45
512 HYPERLIPIDAEMIA 45
513 JOINT INJURY 45
514 NEOPLASM MALIGNANT 45
515 POLYURIA 45
516 SKIN DISORDER 45
517 SUDDEN DEATH 45
518 TOXIC EPIDERMAL NECROLYSIS 45
519 WITHDRAWAL SYNDROME 45
520 ACCIDENTAL EXPOSURE TO PRODUCT 44
521 BONE DISORDER 44
522 CARDIAC FAILURE CHRONIC 44
523 HEPATITIS 44
524 HYPERCALCAEMIA 44
525 HYPERCHOLESTEROLAEMIA 44
526 HYPERPARATHYROIDISM SECONDARY 44
527 LIVER FUNCTION TEST INCREASED 44
528 MENTAL IMPAIRMENT 44
529 MICTURITION URGENCY 44
530 PHOTOSENSITIVITY REACTION 44
531 POLYNEUROPATHY 44
532 PROSTATE CANCER 44
533 ACCIDENTAL OVERDOSE 43
534 ACNE 43
535 BLINDNESS 43
536 FEELING JITTERY 43
537 HYPOKINESIA 43
538 MUSCLE TWITCHING 43
539 PNEUMONIA ASPIRATION 43
540 POTENTIATING DRUG INTERACTION 43
541 SCIATICA 43
542 SEDATION 43
543 THERAPEUTIC PRODUCT EFFECT DECREASED 43
544 URINE OUTPUT DECREASED 43
545 BLOOD URINE PRESENT 42
546 FOOT FRACTURE 42
547 HAIR COLOUR CHANGES 42
548 LOCAL SWELLING 42
549 LUNG NEOPLASM MALIGNANT 42
550 PEMPHIGOID 42
551 PETECHIAE 42
552 PRODUCT STORAGE ERROR 42
553 RASH PAPULAR 42
554 TREATMENT FAILURE 42
555 VIRAL INFECTION 42
556 AGGRESSION 41
557 CARDIOVASCULAR DISORDER 41
558 DERMATITIS 41
559 GINGIVAL BLEEDING 41
560 HYPOTONIA 41
561 PRE-EXISTING CONDITION IMPROVED 41
562 PRODUCT AVAILABILITY ISSUE 41
563 PULMONARY ARTERIAL HYPERTENSION 41
564 RIB FRACTURE 41
565 ROTATOR CUFF SYNDROME 41
566 SHOCK 41
567 SINUS DISORDER 41
568 ABNORMAL BEHAVIOUR 40
569 ARTERIOSCLEROSIS 40
570 BODY HEIGHT DECREASED 40
571 CARPAL TUNNEL SYNDROME 40
572 EYE HAEMORRHAGE 40
573 IMPAIRED GASTRIC EMPTYING 40
574 NEPHROPATHY 40
575 PRODUCT PHYSICAL ISSUE 40
576 TOXIC SKIN ERUPTION 40
577 TRANSAMINASES INCREASED 40
578 TROPONIN INCREASED 40
579 DUODENAL ULCER 39
580 FIBROMYALGIA 39
581 GYNAECOMASTIA 39
582 CANDIDA INFECTION 38
583 CLOSTRIDIUM DIFFICILE INFECTION 38
584 DIVERTICULUM 38
585 DRUG WITHDRAWAL SYNDROME 38
586 FACE OEDEMA 38
587 HAIR TEXTURE ABNORMAL 38
588 HYPOVOLAEMIC SHOCK 38
589 JOINT DISLOCATION 38
590 MENISCUS INJURY 38
591 MULTIPLE SCLEROSIS 38
592 NEOPLASM PROGRESSION 38
593 PROCEDURAL PAIN 38
594 SPINAL FRACTURE 38
595 TOOTH DISORDER 38
596 TOOTHACHE 38
597 UNRESPONSIVE TO STIMULI 38
598 VITAMIN D DEFICIENCY 38
599 BACK DISORDER 37
600 BLOOD ALKALINE PHOSPHATASE INCREASED 37
601 CARDIAC FAILURE ACUTE 37
602 CARDIOMEGALY 37
603 CLOSTRIDIUM DIFFICILE COLITIS 37
604 DERMATITIS ATOPIC 37
605 DRUG DEPENDENCE 37
606 FOETAL EXPOSURE DURING PREGNANCY 37
607 GLOSSODYNIA 37
608 INTENTIONAL SELF-INJURY 37
609 MUSCULOSKELETAL CHEST PAIN 37
610 PRESCRIBED UNDERDOSE 37
611 THIRST 37
612 ACTINIC KERATOSIS 36
613 ANGER 36
614 AORTIC ANEURYSM 36
615 CHOLECYSTECTOMY 36
616 GASTROENTERITIS 36
617 HEPATIC CIRRHOSIS 36
618 HEPATOTOXICITY 36
619 INCREASED APPETITE 36
620 LABORATORY TEST ABNORMAL 36
621 PRODUCT DOSE OMISSION IN ERROR 36
622 REBOUND ACID HYPERSECRETION 36
623 SPINAL PAIN 36
624 SUBARACHNOID HAEMORRHAGE 36
625 THERAPEUTIC RESPONSE SHORTENED 36
626 UROSEPSIS 36
627 VAGINAL HAEMORRHAGE 36
628 ACUTE PULMONARY OEDEMA 35
629 ARTERIOSCLEROSIS CORONARY ARTERY 35
630 BLOOD MAGNESIUM DECREASED 35
631 BREAST PAIN 35
632 COLITIS ULCERATIVE 35
633 CYTOPENIA 35
634 EXTRA DOSE ADMINISTERED 35
635 FEEDING DISORDER 35
636 HEPATIC FAILURE 35
637 KIDNEY TRANSPLANT REJECTION 35
638 OSTEOPENIA 35
639 RENAL CYST 35
640 TASTE DISORDER 35
641 BLOOD CALCIUM DECREASED 34
642 DEAFNESS 34
643 FACIAL PAIN 34
644 GASTRITIS EROSIVE 34
645 INTERNAL HAEMORRHAGE 34
646 MENTAL STATUS CHANGES 34
647 PHOTOPHOBIA 34
648 PNEUMOTHORAX 34
649 PRESCRIBED OVERDOSE 34
650 PRODUCT MONITORING ERROR 34
651 SKIN CANCER 34
652 SNEEZING 34
653 SUPRAVENTRICULAR TACHYCARDIA 34
654 ABASIA 33
655 ANKLE FRACTURE 33
656 BLOOD URIC ACID INCREASED 33
657 CARDIOMYOPATHY 33
658 DERMATITIS ALLERGIC 33
659 GASTROENTERITIS VIRAL 33
660 INCORRECT DRUG ADMINISTRATION DURATION 33
661 MOUTH ULCERATION 33
662 PLATELET COUNT INCREASED 33
663 PRODUCT ADMINISTRATION ERROR 33
664 RENAL TUBULAR DISORDER 33
665 SKIN HAEMORRHAGE 33
666 SKIN REACTION 33
667 ANHEDONIA 32
668 ARTERIAL OCCLUSIVE DISEASE 32
669 BLOOD LACTIC ACID INCREASED 32
670 BLOOD THYROID STIMULATING HORMONE INCREASED 32
671 CUTANEOUS LUPUS ERYTHEMATOSUS 32
672 EATING DISORDER 32
673 INJECTION SITE MASS 32
674 INTERVERTEBRAL DISC DEGENERATION 32
675 KNEE ARTHROPLASTY 32
676 LYMPHOPENIA 32
677 MALIGNANT MELANOMA 32
678 MOOD ALTERED 32
679 MUSCLE RIGIDITY 32
680 PYELONEPHRITIS 32
681 QUALITY OF LIFE DECREASED 32
682 SCRATCH 32
683 SENSORY DISTURBANCE 32
684 WRIST FRACTURE 32
685 BLOOD COUNT ABNORMAL 31
686 BLOOD CREATININE ABNORMAL 31
687 BLOOD GLUCOSE FLUCTUATION 31
688 BONE MARROW FAILURE 31
689 COLITIS MICROSCOPIC 31
690 DERMATITIS CONTACT 31
691 EAR DISCOMFORT 31
692 HAEMODYNAMIC INSTABILITY 31
693 INCREASED TENDENCY TO BRUISE 31
694 INITIAL INSOMNIA 31
695 INJECTION SITE RASH 31
696 LOW DENSITY LIPOPROTEIN INCREASED 31
697 MALABSORPTION 31
698 MALNUTRITION 31
699 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31
700 PARKINSONISM 31
701 PROSTATIC SPECIFIC ANTIGEN INCREASED 31
702 PURPURA 31
703 RENAL TUBULAR NECROSIS 31
704 SECRETION DISCHARGE 31
705 SKIN FISSURES 31
706 SYSTEMIC INFECTION 31
707 VASCULAR PURPURA 31
708 BLOOD TESTOSTERONE DECREASED 30
709 CONCUSSION 30
710 CYANOSIS 30
711 CYTOKINE RELEASE SYNDROME 30
712 DELUSION 30
713 FAECALOMA 30
714 GENERALISED OEDEMA 30
715 LIBIDO DECREASED 30
716 MYOSITIS 30
717 NERVE INJURY 30
718 ORAL HERPES 30
719 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 30
720 PHARYNGEAL OEDEMA 30
721 PRODUCT TASTE ABNORMAL 30
722 RENAL CANCER 30
723 STAPHYLOCOCCAL BACTERAEMIA 30
724 ABNORMAL LOSS OF WEIGHT 29
725 ACTIVITIES OF DAILY LIVING IMPAIRED 29
726 APATHY 29
727 BUNDLE BRANCH BLOCK LEFT 29
728 CORONAVIRUS INFECTION 29
729 DIVERTICULUM INTESTINAL 29
730 ECCHYMOSIS 29
731 FREQUENT BOWEL MOVEMENTS 29
732 HYPOAESTHESIA ORAL 29
733 HYPOPARATHYROIDISM 29
734 IMPAIRED WORK ABILITY 29
735 INFUSION SITE PAIN 29
736 LYMPHOEDEMA 29
737 MOOD SWINGS 29
738 ORAL CANDIDIASIS 29
739 PAIN OF SKIN 29
740 PSYCHOMOTOR HYPERACTIVITY 29
741 SINUS CONGESTION 29
742 SUPRAVENTRICULAR EXTRASYSTOLES 29
743 VITAMIN D DECREASED 29
744 WEIGHT FLUCTUATION 29
745 AORTIC VALVE INCOMPETENCE 28
746 APHTHOUS ULCER 28
747 APPLICATION SITE PRURITUS 28
748 BLOOD TEST ABNORMAL 28
749 CEREBRAL INFARCTION 28
750 DEFAECATION URGENCY 28
751 EAR PAIN 28
752 FEBRILE BONE MARROW APLASIA 28
753 LIP OEDEMA 28
754 MADAROSIS 28
755 MUSCLE ATROPHY 28
756 PRODUCT ADHESION ISSUE 28
757 PRODUCT ADMINISTRATION INTERRUPTED 28
758 PRODUCT ODOUR ABNORMAL 28
759 PRODUCT USE COMPLAINT 28
760 SKIN IRRITATION 28
761 TONGUE OEDEMA 28
762 ULCER 28
763 BENIGN PROSTATIC HYPERPLASIA 27
764 BLINDNESS UNILATERAL 27
765 COORDINATION ABNORMAL 27
766 CRANIOCEREBRAL INJURY 27
767 DIZZINESS POSTURAL 27
768 DRUG RESISTANCE 27
769 EMOTIONAL DISORDER 27
770 ESCHERICHIA INFECTION 27
771 GENERALISED TONIC-CLONIC SEIZURE 27
772 HAIR DISORDER 27
773 INSURANCE ISSUE 27
774 LOWER LIMB FRACTURE 27
775 LUNG INFECTION 27
776 METASTASES TO LIVER 27
777 MIOSIS 27
778 MYOPATHY 27
779 OBSTRUCTIVE SLEEP APNOEA SYNDROME 27
780 ORTHOSTATIC INTOLERANCE 27
781 PARAESTHESIA ORAL 27
782 POLYP 27
783 RALES 27
784 RENAL FUNCTION TEST ABNORMAL 27
785 RESPIRATORY ARREST 27
786 SKIN EROSION 27
787 SKIN LACERATION 27
788 SNORING 27
789 UPPER-AIRWAY COUGH SYNDROME 27
790 ACIDOSIS 26
791 ADRENAL INSUFFICIENCY 26
792 BLOOD IRON DECREASED 26
793 CHOLECYSTITIS 26
794 CONGESTIVE CARDIOMYOPATHY 26
795 CUTANEOUS VASCULITIS 26
796 DYSLIPIDAEMIA 26
797 ESSENTIAL HYPERTENSION 26
798 HAEMORRHAGE INTRACRANIAL 26
799 HEPATITIS ACUTE 26
800 HEREDITARY ANGIOEDEMA 26
801 METASTASES TO BONE 26
802 METASTASES TO LUNG 26
803 PARKINSON^S DISEASE 26
804 PULMONARY CONGESTION 26
805 PULMONARY THROMBOSIS 26
806 SMALL FOR DATES BABY 26
807 STEVENS-JOHNSON SYNDROME 26
808 THINKING ABNORMAL 26
809 TOOTH ABSCESS 26
810 TOOTH FRACTURE 26
811 UVEITIS 26
812 AKINESIA 25
813 ATELECTASIS 25
814 ATRIAL FLUTTER 25
815 BLOOD GLUCOSE ABNORMAL 25
816 BLOOD LACTATE DEHYDROGENASE INCREASED 25
817 BOWEL MOVEMENT IRREGULARITY 25
818 CACHEXIA 25
819 CONJUNCTIVITIS 25
820 CORONARY ARTERIAL STENT INSERTION 25
821 EPIGASTRIC DISCOMFORT 25
822 GASTRIC ULCER HAEMORRHAGE 25
823 HAEMATOMA MUSCLE 25
824 HYPOTHERMIA 25
825 IDIOPATHIC PULMONARY FIBROSIS 25
826 IMMUNE SYSTEM DISORDER 25
827 IMPAIRED QUALITY OF LIFE 25
828 INFLAMMATORY MARKER INCREASED 25
829 LARYNGITIS 25
830 LEFT VENTRICULAR HYPERTROPHY 25
831 LIPASE INCREASED 25
832 MACULAR DEGENERATION 25
833 MOUTH HAEMORRHAGE 25
834 MUSCULOSKELETAL DISORDER 25
835 NEOPLASM 25
836 PERIPHERAL VENOUS DISEASE 25
837 RENAL PAIN 25
838 THYROID DISORDER 25
839 VITAMIN B12 DECREASED 25
840 APPLICATION SITE ERYTHEMA 24
841 BACK INJURY 24
842 BEDRIDDEN 24
843 BLADDER TRANSITIONAL CELL CARCINOMA 24
844 BLOOD THYROID STIMULATING HORMONE DECREASED 24
845 CHOKING 24
846 DECUBITUS ULCER 24
847 DEVICE OCCLUSION 24
848 DIALYSIS 24
849 DRUG ERUPTION 24
850 EXOSTOSIS 24
851 FOOT DEFORMITY 24
852 GLOMERULAR FILTRATION RATE ABNORMAL 24
853 HYPERURICAEMIA 24
854 MELANOCYTIC NAEVUS 24
855 MYOCARDITIS 24
856 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 24
857 NEPHROPATHY TOXIC 24
858 NERVE COMPRESSION 24
859 OCULAR DISCOMFORT 24
860 PRODUCT DISPENSING ERROR 24
861 SCAB 24
862 SINUS ARREST 24
863 SINUS HEADACHE 24
864 SPINAL DISORDER 24
865 SPINAL OPERATION 24
866 TOOTH INFECTION 24
867 UPPER LIMB FRACTURE 24
868 VENTRICULAR FIBRILLATION 24
869 VITREOUS FLOATERS 24
870 WRONG PATIENT RECEIVED PRODUCT 24
871 ATAXIA 23
872 BACTERIAL INFECTION 23
873 BLOOD POTASSIUM ABNORMAL 23
874 DEVICE DISLOCATION 23
875 DIABETIC NEPHROPATHY 23
876 DIASTOLIC DYSFUNCTION 23
877 FLUID OVERLOAD 23
878 HEPATOMEGALY 23
879 HIP ARTHROPLASTY 23
880 HUNGER 23
881 INFUSION SITE ERYTHEMA 23
882 LARGE INTESTINE POLYP 23
883 LEFT VENTRICULAR FAILURE 23
884 LYMPHOCYTE COUNT DECREASED 23
885 MIGRAINE WITH AURA 23
886 MULTIPLE ALLERGIES 23
887 OBESITY 23
888 ONYCHOCLASIS 23
889 PHARYNGITIS 23
890 POST PROCEDURAL HAEMORRHAGE 23
891 PROTEIN URINE PRESENT 23
892 PSYCHOTIC DISORDER 23
893 RESPIRATORY TRACT CONGESTION 23
894 SINUS NODE DYSFUNCTION 23
895 SLUGGISHNESS 23
896 AORTIC STENOSIS 22
897 AZOTAEMIA 22
898 BLADDER DISORDER 22
899 BRONCHOPULMONARY ASPERGILLOSIS 22
900 BUNDLE BRANCH BLOCK RIGHT 22
901 COELIAC DISEASE 22
902 CONCOMITANT DISEASE AGGRAVATED 22
903 DERMATITIS BULLOUS 22
904 DRUG EFFECT LESS THAN EXPECTED 22
905 DRY THROAT 22
906 ESCHERICHIA URINARY TRACT INFECTION 22
907 FLANK PAIN 22
908 GASTROINTESTINAL PAIN 22
909 HAEMORRHOIDAL HAEMORRHAGE 22
910 HEMIPLEGIA 22
911 INJECTION SITE URTICARIA 22
912 INTRAOCULAR PRESSURE INCREASED 22
913 MICROCYTIC ANAEMIA 22
914 NEUTROPENIC SEPSIS 22
915 NO THERAPEUTIC RESPONSE 22
916 PANCREATIC CARCINOMA 22
917 POLYCYTHAEMIA 22
918 POST PROCEDURAL COMPLICATION 22
919 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22
920 SCAR 22
921 SINUS TACHYCARDIA 22
922 SMALL INTESTINAL OBSTRUCTION 22
923 THERAPY PARTIAL RESPONDER 22
924 THYROID FUNCTION TEST ABNORMAL 22
925 TOOTH EXTRACTION 22
926 TUMOUR LYSIS SYNDROME 22
927 URINE OUTPUT INCREASED 22
928 AFFECTIVE DISORDER 21
929 AORTIC VALVE STENOSIS 21
930 CATHETERISATION CARDIAC 21
931 CENTRAL NERVOUS SYSTEM LESION 21
932 CHONDROPATHY 21
933 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 21
934 FRACTURE 21
935 HAEMOLYTIC ANAEMIA 21
936 HALLUCINATION, AUDITORY 21
937 HEART RATE ABNORMAL 21
938 HEPATITIS CHOLESTATIC 21
939 INTERNATIONAL NORMALISED RATIO DECREASED 21
940 JOINT RANGE OF MOTION DECREASED 21
941 LACERATION 21
942 LICHEN PLANUS 21
943 MATERNAL EXPOSURE DURING PREGNANCY 21
944 MONOPARESIS 21
945 NEPHROTIC SYNDROME 21
946 NORMOCYTIC ANAEMIA 21
947 ONYCHOMYCOSIS 21
948 PERIPHERAL MOTOR NEUROPATHY 21
949 PERITONITIS 21
950 RETROPERITONEAL HAEMATOMA 21
951 RIGHT VENTRICULAR FAILURE 21
952 SPLENOMEGALY 21
953 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 21
954 THERAPY CHANGE 21
955 TRANSFUSION 21
956 VENTRICULAR HYPOKINESIA 21
957 ANGINA UNSTABLE 20
958 ATRIAL TACHYCARDIA 20
959 BRAIN NATRIURETIC PEPTIDE INCREASED 20
960 CAROTID ARTERY STENOSIS 20
961 DISABILITY 20
962 DRUG DISPENSING ERROR 20
963 ENERGY INCREASED 20
964 ENURESIS 20
965 ERYSIPELAS 20
966 ESCHERICHIA SEPSIS 20
967 FACIAL PARESIS 20
968 GROIN PAIN 20
969 HAEMORRHAGIC DIATHESIS 20
970 HOSPICE CARE 20
971 HYPERTRANSAMINASAEMIA 20
972 INCONTINENCE 20
973 ISCHAEMIA 20
974 LOWER GASTROINTESTINAL HAEMORRHAGE 20
975 METABOLIC DISORDER 20
976 METABOLIC ENCEPHALOPATHY 20
977 MUSCLE RUPTURE 20
978 OSTEOCHONDROSIS 20
979 PARALYSIS 20
980 PERIARTHRITIS 20
981 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 20
982 PROTHROMBIN TIME PROLONGED 20
983 RAYNAUD^S PHENOMENON 20
984 VENTRICULAR ARRHYTHMIA 20
985 ABSCESS LIMB 19
986 APPLICATION SITE PAIN 19
987 BLOOD ALBUMIN DECREASED 19
988 BLOOD CALCIUM INCREASED 19
989 COLON CANCER 19
990 CYST 19
991 ECONOMIC PROBLEM 19
992 FOOD ALLERGY 19
993 GASTROINTESTINAL INFECTION 19
994 GLOSSITIS 19
995 GOITRE 19
996 HYPERBILIRUBINAEMIA 19
997 HYPERLACTACIDAEMIA 19
998 HYPERTHERMIA 19
999 HYPOPHOSPHATAEMIA 19